PremiumCompany AnnouncementsEvaxion Biotech Reports Q2 2025 Financial Results with Notable Losses Evaxion Biotech reports Q2 EPS (2c) vs (12c) last year Evaxion A/S to Present Q2 2025 Financial Results and Business Update PremiumThe FlyEvaxion Biotech finalizes agreement with EIB to convert debt into equity Evaxion A/S Announces Executive Changes to Boost AI-Immunology Platform Evaxion Biotech announces Kanstrup has stepped down as CEO PremiumCompany AnnouncementsEvaxion Biotech’s Earnings Call Highlights Progress and Challenges Evaxion Biotech: Promising Pipeline and Strategic Collaborations Drive Buy Rating Evaxion Biotech Reports Q1 2025 Progress and Financials